Johnson & Johnson (JNJ)

256.33
-0.65 (-0.25%)
NYSE· Last Trade: Aug 7th, 1:43 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close256.98
Open255.89
Bid256.33
Ask256.45
Day's Range255.12 - 258.02
52 Week Range169.68 - 274.90
Volume1,861,815
Market Cap673.81B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield5.360 (2.09%)
1 Month Average Volume8,011,754

Chart

About Johnson & Johnson (JNJ)

Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More

News & Press Releases

Solventum Nears Inflection Point As It Begins to Unlock Valuemarketbeat.com
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.
Via MarketBeat · August 7, 2026
Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.fool.com
These healthcare giants can deliver steady gains.
Via The Motley Fool · August 6, 2026
The Market Is Flashing a Valuation Warning -- but History Shows These Stocks Can Handle the Turbulencefool.com
Investors may want to brace for turbulence. But these stocks should hold up well.
Via The Motley Fool · August 6, 2026
What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · August 5, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · August 5, 2026
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
Issued on behalf of Helus Pharma (Nasdaq: HELP)
By USA News Group · Via GlobeNewswire · August 5, 2026
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
By Johnson & Johnson · Via Business Wire · August 4, 2026
Which dow jones stocks are moving on Tuesday?chartmill.com
Via Chartmill · August 4, 2026
Tuesday's session: top gainers and losers in the dow jones indexchartmill.com
Via Chartmill · August 4, 2026
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)
By American News Group · Via GlobeNewswire · August 4, 2026
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine following a distinguished career and over 21-year tenure at Johnson & Johnson. Under her leadership, the Company’s Innovative Medicine business grew to more than $60 billion in annual revenue and strengthened its position as one of the most respected and successful pharmaceutical businesses in the world.
By Johnson & Johnson · Via Business Wire · August 4, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · August 3, 2026
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposuremarketbeat.com
As the NASDAQ-100 corrects amid an AI CapEx-driven tech sell-off, sectors like healthcare and financials are rallying, boosting diversified value ETFs like the Schwab U.S. Large-Cap Value ETF (SCHV).
Via MarketBeat · August 3, 2026
Top dow jones movers in Monday's sessionchartmill.com
Via Chartmill · August 3, 2026
Johnson & Johnson’s OTTAVA Robotic Surgery System Targets Long-Term Growthmarketbeat.com
Johnson & Johnson (NYSE:JNJ) outlined its commercialization plans for the OTTAVA robotic surgical system after receiving U.S. Food and Drug Administration De Novo authorization, positioning the table-integrated platform as a long-term growth initiative in surgical robotics. The company said it
Via MarketBeat · August 3, 2026
3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026fool.com
As stocks pull back from recent highs, lean into these three blue chip dividend stocks.
Via The Motley Fool · August 2, 2026
3 Dividend Stocks to Buy and Hold Foreverfool.com
They have a combined 181 years of consecutive payout increases.
Via The Motley Fool · August 1, 2026
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Abbott trades at a cheaper valuation but carries higher litigation risk, while J&J boasts superior profitability despite a pending talc settlement.
Via The Motley Fool · July 31, 2026
These dow jones stocks are moving in today's sessionchartmill.com
Via Chartmill · July 31, 2026
Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipelinebenzinga.com
Johnson & Johnson (NYSE: JNJ) shares are edging higher on Friday as investors digest two major biotech pipeline moves.
Via Benzinga · July 31, 2026
Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited Aboutfool.com
Things are going well for the pharmaceutical giant.
Via The Motley Fool · July 30, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · July 30, 2026
Which dow jones stocks are moving on Thursday?chartmill.com
Via Chartmill · July 30, 2026
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Dealsbenzinga.com
Johnson & Johnson expands its biotech pipeline with Firefly Bio acquisition and a strategic partnership with Sail Biomedicines.
Via Benzinga · July 30, 2026
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Nowfool.com
But is that performance sustainable?
Via The Motley Fool · July 29, 2026